NFE2L2 and cardiomyopathy: HMOX1 was involved in ferroptosis-mediated doxorubicin (DOX)-induced cardiomyopathy (DIC) through the accumulation of non-heme iron in response to Nrf2, which could be rescued by a HMOX1 antagonist or Nrf2-deficiency in mice [37].